Background Most individuals with malignant peritoneal mesothelioma (MPM) present with late-stage unresectable disease that responds poorly to systemic chemotherapy while Rabbit polyclonal to CLIC1. at the same time effective targeted therapies are lacking. of 37 weeks median overall survival was 46.2 months with 1- 2 and 5-yr overall survival probability of 77 57 and 39… Continue reading Background Most individuals with malignant peritoneal mesothelioma (MPM) present with late-stage